Rate My Professor Vanessa Murphy

Murphy's research investigates the characteristics, mechanisms, and consequences of asthma exacerbations during pregnancy and their impact on maternal and infant health, aiming for intergenerational benefits through improved asthma management. She is Chief Investigator on the Treatable Traits for Asthma Management in Pregnancy (TTAP) Study, extending findings from the Breathing for Life Trial (BLT), a multi-centre randomized controlled trial of inflammation-based asthma management during pregnancy. The BLT birth cohort examines perinatal outcomes, childhood wheeze and asthma development, and the effects of bushfire smoke exposure during pregnancy on child health. Her specializations include respiratory diseases, perinatal outcomes, infant and child health, obstetrics, and gynaecology. Key publications include "Asthma in Pregnancy" (2021), "Asthma – interrelationships with pregnancy" (2019), "Asthma and rhinitis in pregnancy" (2010), "Effect of asthma management with exhaled nitric oxide versus usual care on perinatal outcomes" (2022), "A Prospective Study of Respiratory Viral Infection in Pregnant Women With and Without Asthma" (2013, Chest), and "Management of Asthma in Pregnancy Guided by Measurement of Fraction of Exhaled Nitric Oxide" (2011, The Lancet). Among her honors are the Hunter Medical Research Institute Director's Award for Mid-Career Research (2024), European Respiratory Society Young Scientist Sponsorship (2005), Elsevier Science New Investigator Award (2003), and Australian Society for Medical Research Research Award (2002). Her work has provided evidence for novel asthma management strategies in pregnancy, improving health outcomes for mothers and their children into preschool age.